Pelvic recurrences of ovarian cancer: sonographic visualization and magnetic resonance imaging

Close metadata

OBJECTIVE

To clarify semiotics, the type and nature of recurrent ovarian tumors according to magnetic resonance imaging and ultrasonography.

MATERIAL AND METHODS

The study included 36 patients with stage III-IV recurrent ovarian cancer with no residual tumor after comprehensive treatment according to radiation methods between 2011 and 2022. Ultrasound examination using high-tech methods was performed on the eSaote Pro device, multiparametric magnetic resonance examination of the pelvic organs was performed on a high-field tomograph with a magnetic field strength of 1.5 Tesla.

RESULTS

Modern ultrasound methods alone or in combination with MRI allow to obtain information about the degree of spread of recurrent ovarian tumor process in the pelvis and to assess the effectiveness of the ongoing drug treatment.

The sensitivity of complex ultrasonography was 91.6%, specificity 97.2%, positive predictive value — 97%, negative predictive value — 92%. The accuracy of the MRI method in diagnosing recurrent ovarian tumors in the pelvis was 93.5%.

CONCLUSION

Complex application of modern radial diagnostic methods within the limits of resolution and diagnostic significance provides comprehensive information about the localization of recurrent ovarian tumor, spread of the tumor process, as well as allows to assess the indicators of neoangiogenesis, which significantly affects the choice of further treatment.

Keywords:

MRI

ultrasound

recurrent ovarian cancer

ROC

serous ovarian carcinoma

Authors:

Nudnov N.V.

National Medical Radiology Research Center;
Peoples’ Friendship University of Russia named after Patrice Lumumba;
Russian Medical Academy of Continuous Professional Education

ORCID: 0000-0001-5994-0468

Aksenova S.P.

National Medical Radiology Research Center

ORCID: 0000-0003-2552-5754

Ivashina S.V.

National Medical Radiology Research Center

ORCID: 0000-0002-9287-2636

Received:

14.08.2023

Accepted:

03.11.2023

List of references:

Kaprin AD, Starinskii VV, Shakhzadova AO, eds. The state of oncological care for the population of Russia in 2020. M.: MNIOI named after P.A. Herzen — branch of the Federal State Budgetary Institution «NMITs Radiology» of the Ministry of Health of Russia; 2021;239. (In Russ.).
Manganaro L, Gigli S, Antonelli A, Saldari M, Tomao F, Marchetti C, Anastasi E, Laghi A. Imaging strategy in recurrent ovarian cancer: a practical review. Abdom Radiol (NY). 2019;44(3):1091-1102. https://doi.org/10.1007/s00261-018-1677-y
Hennessy BT, Coleman RL, Markman M. Ovarian cancer. Lancet. 2009;374(9698):1371-1382. https://doi.org/10.1016/S0140-6736(09)61338-6
Bulanova IM, Bulanova TV, Burenchev DV. Ultrasound and magnetic resonance diagnostics of relapses and metastases of ovarian cancer. Bulletin of Roentgenology and Radiology. 2006;(1):53-58. (In Russ.).
Ozerskaya IA, Chekalova MA, Ivanov VA, Kazaryan GG. Ultrasound signs of ovarian tumors according to a standardized protocol. Medical Imaging. 2023;27(2):110-124. (In Russ.). https://doi.org/10.24835/1607-0763-1144
Ivashina SV, Antonova IB, Babaeva NA, Aleshikova OI, Ashrafyan LA. The role of modern ultrasound methods in the early diagnosis of recurrence of ovarian cancer. Difficult Patient. 2018;16(8-9):12-15. (In Russ.). https://doi.org/10.24411/2074-1995-2018-10002
Antonova IB, Ivashina SV, Ashrafyan LA, Babaeva NA, Aleshikova OI. Criteria for the choice of diagnostic methods in patients with recurrent ovarian cancer. Bulletin of the Russian Scientific Center of Roentgenoradiology of the Ministry of Healthcare of the Russian Federation. 2018;18(4):16-28. (In Russ.). Available at: https://vestnik.rncrr.ru/vestnikrncrr/vestnik/v18/v18.htm
Ivashina SV, Antonova IB, Aleshikova OI, Ashrafyan LA. Modern ultrasound diagnostics in the early detection of ovarian cancer relapses. Obstetrics and Gynecology. News. Opinions. Education. 2019;7(1):39-45. (In Russ.).
Huang Q, Zeng Z. A review on real-time 3D ultrasound imaging technology. Biomed Res Int. 2017;2017:6027029. https://doi.org/10.1155/2017/6027029
Singh K, Malhotra N. Step by step: 3D/4D ultrasound in obstetrics, gynecology and infertility. 2nd ed. Jaupee Brothers Medical Pub; 2013;133.
Sala E, Kataoka MY, Priest AN, Gill AB, McLean MA, Joubert I, Graves MJ, Crawford RA, Jimenez-Linan M, Earl HM, et al. Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effects. Radiology. 2012;263(1):149-159. https://doi.org/10.1148/radiol.11110175
Low RN, Duggan B, Barone RM, Saleh F, Song SY. Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year. Radiology. 2005;235(3):918-926. https://doi.org/10.1148/radiol.2353040447
Gu P, Pan LL, Wu SQ, Sun L, Huang G. CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis. Eur J Radiol. 2009;71(1):164-174. https://doi.org/10.1016/j.ejrad.2008.02.019
Forstner R, Thomassin-Naggara I, Cunha TM, Kinkel K, Masselli G, Kubik-Huch R, Spencer JA, Rockall A. ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update. Eur Radiol. 2017;27(6):2248-2257. https://doi.org/10.1007/s00330-016-4600-3
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-E386. https://doi.org/10.1002/ijc.29210
Amate P, Huchon C, Dessapt AL, Bensaid C, Medioni J, Le Frère Belda MA, Bats AS, Lécuru FR. Ovarian cancer: sites of recurrence. Int J Gynecol Cancer. 2013;23(9):1590-1596. https://doi.org/10.1097/IGC.0000000000000007
Dao MD, Alwan LM, Gray HJ, Tamimi HK, Goff BA, Liao JB. Recurrence patterns after extended treatment with bevacizumab for ovarian, fallopian tube, and primary peritoneal cancers. Gynecol Oncol. 2013;130(2):295-299. https://doi.org/10.1016/j.ygyno.2013.04.055
Aksenova SP, Nudnov NV, Kreinina YuM. Magnetic resonance imaging of the vagina and pelvis in women undergoing anticancer treatment for cancer of the female genital organs. Medical Imaging. 2017;21(2):131-139. (In Russ.). https://doi.org/10.24835/1607-0763-2017-2-131-139
Kinkel K, Hricak H, Lu Y, Tsuda K, Filly RA. US characterization of ovarian masses: a meta-analysis. Radiology. 2000;217(3):803-811. https://doi.org/10.1148/radiology.217.3.r00dc20803
Testa AC, Di Legge A, Virgilio B, Bonatti M, Manfredi R, Mirk P, Rufini V. Which imaging technique should we use in the follow up of gynaecological cancer? Best Pract Res Clin Obstet Gynaecol. 2014;28(5):769-791. https://doi.org/10.1016/j.bpobgyn.2014.04.008
Rosati A, Gueli Alletti S, Capozzi VA, Mirandola M, Vargiu V, Fedele C, Uccella S, Vascone C. Role of ultrasound in the detection of recurrent ovarian cancer: a review of the literature. Gland Surg. 2020;9(4):1092-1101. https://doi.org/10.21037/gs-20-357
Ricke J, Sehouli J, Hach C, Hänninen EL, Lichtenegger W, Felix R. Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer. Eur Radiol. 2003;13(5):943-949. https://doi.org/10.1007/s00330-002-1712-8
Kim CK, Park BK, Choi JY, Kim BG, Han H. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT. J Comput Assist Tomogr. 2007;31(6):868-875. https://doi.org/10.1097/rct.0b013e31803e8c45
Olimov BP, Beregov MM, Kossov FA, Lapteva MG, Strel’tsova ON, Panichenko IV, Panov VO, Zhordania KI, Tyurin IE. Dynamic MRI with contrast enhancement in the differential diagnosis of adnexal tumors. Oncogynecology. 2019;(2):43-57. (In Russ.). https://doi.org/10.52313/22278710_2019_2_43
Hameeduddin A, Sahdev A. Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies. Cancer Imaging. 2015;15(1):3. https://doi.org/10.1186/s40644-015-0037-1
Fehniger J, Thomas S, Lengyel E, Liao C, Tenney M, Oto A, Yamada SD. A prospective study evaluating diffusion weighted magnetic resonance imaging (DW-MRI) in the detection of peritoneal carcinomatosis in suspected gynecologic malignancies. Gynecol Oncol. 2016;142(1):169-175. https://doi.org/10.1016/j.ygyno.2016.04.018
Winfield JM, Wakefield JC, Dolling D, Hall M, Freeman S, Brenton JD, Lutchman-Singh K, Pace E, Priest AN, Quest RA, et al. Diffusion-weighted MRI in advanced epithelial ovarian cancer: apparent diffusion coefficient as a response marker. Radiology. 2019;293(2):374-383. https://doi.org/10.1148/radiol.2019190545
Low RN, Sebrechts CP, Barone RM, Muller W. Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings — a feasibility study. AJR Am J Roentgenol. 2009;193(2):461-470. https://doi.org/10.2214/AJR.08.1753
Rubtsova NA, Novikova EG, Sychenkova IYu. Modern possibilities of magnetic resonance imaging in the diagnosis of ovarian cancer. Research and Practice in Medicine. 2017;4(1):40-48. (In Russ.). https://doi.org/10.17709/2409-2231-2017-4-1-5
Arai K, Makino H, Morioka T, Yagi H, Minabe K, Takeyama S, Takashima T, Terayama N, Matsui O, Kadoya M. Enhancement of ascites on MRI following intravenous administration of Gd-DTPA. J Comput Assist Tomogr. 1993;17(4):617-622. https://doi.org/10.1097/00004728-199307000-00019

Close metadata